|Min. Order:||1 Kilogram|
|Delivery Time:||7 Days|
Model No.: 127852-28-2
Place of Origin: CHINA
Catering to the varied requirements of our clients we offer superior quality Aprepitant Intermediates CAS 127852-28-2. Aprepitant Intermediates CAS NO 127852-28-2 is well-known for its high purit, fast action and safety. Experiment shows good response in prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) and for prevention of postoperative nausea and vomiting. We are reputed and honest supplier in China, we only offer quality guaranteed Aprepitant Intermediates 127852-28-2. We accept both customization and mass production.
l Thera. Category:Anti- emetic
l Cas No.: 127852-28-2
l Synonym:R-MBT-PEL;(R)-BIS-3,5-TRIFLUOROMETHYL-1-PHENYLETHANOL;(R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHANOL;(R)-1-[BIS-3,5-(TRIFLUOROMETHYL)PHENYL]ETHANOL;(1R)-1-[3,6-BIS(TRIFLUOROMETHYL)PHENYL]ETHANOL;(R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHAN-1-OL;(R)-1-[3,5-BIS(TRIFLUORO-METHYL)-PHENYL]ETHANOL 98%;(1R)-(+)-1-[3,5-Bis(trifluoromethyl)phenyl]ethan-1-ol;
l Molecular Formula: C10H8F6O
l Molecular Weight:258.16
l Assay: ≥98%
l Packing:Export worthy packing
l Material Safety Data Sheet:Available on request
l Usage: Intermediate of Aprepitant
Aprepitant (brand name: Emend (the brand name used in all English-speaking countries)) is an antiemetic chemical compound .Aprepitant is manufactured by Merk&Co. under the brand name Emend for prevention of acute and delayed CINV) and for prevention of postoperative nausea and vomiting. It was approved by the FDA in 2003.
Aprepitant may also be useful in the treatment of cyclic vomiting syndrome & late-stage chemotherapy induced vomiting, but there are few studies to date.
On January 2008, the FDA approved fosaprepitant, an intravenous form of aprepitant, which is to be sold under the tradename Emend Injection in the US and as Ivemend in some other countries.